Patient on Esketamine had Improved Depression, Fibromyalgia
Treatment-resistant depression with intranasal esketamine was linked to improvements in major depressive disorder (MDD) symptoms and fibromyalgia pain in a 40-year-old female.
Stay updated with breaking news from Depressive Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment-resistant depression with intranasal esketamine was linked to improvements in major depressive disorder (MDD) symptoms and fibromyalgia pain in a 40-year-old female.
In this article, we will be taking a look at the 20 most depressed countries in Asia.
In this article, we will be taking a look at the 20 most depressed countries in Asia. If you do not want to learn about the Asian depression market, head straight to the 5 Most Depressed Countries in Asia. Overview of the Global and Asian Depression Market The global depression market is a significant sector […]
In this article, we will be taking a look at the 30 countries with the lowest depression rates.
Psychiatry’s depression outcomes are poor because its treatments are based on a depression model that science has flushed down the toilet.